A CRISPR-Based Solution to the Problem of alpha1-Antitrypsin Deficiency – Genetic Engineering & Biotechnology News
|
A CRISPR-Based Solution to the Problem of alpha1-Antitrypsin Deficiency
Genetic Engineering & Biotechnology News α1-Antitrypsin deficiency (AATD) is a single-gene disorder, particularly common in Scandinavia, Ireland, Northern Europe, and North America. The carrier frequency, which is approximately 3% in the United States, reaches as high as 25% among chronic … |
